Prevalence of Pulmonary Tuberculosis among Prison Inmates in Ethiopia, a Cross-Sectional Study

PLoS One. 2015 Dec 7;10(12):e0144040. doi: 10.1371/journal.pone.0144040. eCollection 2015.

Abstract

Setting: Tuberculosis (TB) is one of the major health problems in prisons.

Objective: This study was done to assess the prevalence and determinants of active tuberculosis in Ethiopian prisons.

Design: A cross-sectional study was conducted from January 2013 to December 2013 in 13 zonal prisons. All incarcerated inmates underwent TB symptom screening according to WHO criteria. From identified TB-suspects two sputum samples were analyzed using smear microscopy and solid culture. A standardized questionnaire assessing TB risk factors was completed for each TB suspect.

Results: 765 (4.9%) TB suspects were identified among 15,495 inmates. 51 suspects were already on anti-TB treatment (6.67%) and 20 (2.8%) new culture-confirmed TB cases were identified in the study, resulting in an overall TB prevalence of 458.1/100,000 (95%CI: 350-560/100,000). Risk factors for active TB were alcohol consumption, contact with a TB case before incarceration and no window in prison cell. HIV prevalence was not different between TB suspects and active TB cases. Further, the TB burden in prisons increased with advancing distance from the capital Addis Ababa.

Conclusions: The overall TB prevalence in Ethiopian prisons was high and extremely variable among different prisons. TB risk factors related to conditions of prison facilities and the impact of implemented TB control measures need to be further studied in order to improve TB control among inmates.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Ethiopia / epidemiology
  • Female
  • Humans
  • Male
  • Prevalence
  • Prisoners*
  • Prisons*
  • Risk Factors
  • Tuberculosis, Pulmonary / epidemiology*
  • Tuberculosis, Pulmonary / therapy

Grants and funding

The study was financially supported by European and developing countries Clinical trials partnership (EDCTP) Grant number SP.2011.41304.022 (http://www.edctp.org/). The funder has no role in study design, data collection, analysis, decision to publish and preparation of this manuscript.